GlassScriptPhysician profile
Matthew C Ralstin
NPI 1104088731
$2,584.01
in general payments reported to CMS, 2019-2025
23 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $59.92 · 2021: $121 · 2022: $379 · 2023: $742 · 2024: $418 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,593 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,592.62 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $581.04 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Glaukos Corporation | $501.78 | 2019-2025 | Idosetr, Idose, Istent Infinite |
| Rxsight INC | $456.69 | 2022-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Abbvie INC. | $159.13 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $156.60 | 2019 | |
| Sight Sciences, INC. | $149.26 | 2021-2022 | |
| Genentech USA, INC. | $84.84 | 2023-2025 | Vabysmo |
| Ocular Therapeutix, INC. | $68.41 | 2023-2025 | Dextenza |
| New World Medical,INC. | $52.69 | 2021-2025 | Streamline, Kahook Dual Blade, Clearpath |
| Bausch & Lomb Americas INC. | $50.41 | 2023-2024 | Envista Mx60 Iol, Ic-8 Apthera Iol |
| Astellas Pharma US INC | $40.51 | 2023-2025 | Izervay |
| Omeros Corporation | $35.86 | 2020 | |
| Apellis Pharmaceuticals, INC. | $35.17 | 2022-2023 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $34.23 | 2023-2024 | Eylea Hd, Eylea |
| Carl Zeiss Meditec, INC. | $31.60 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $24.33 | 2023 | Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $21.35 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $20.40 | 2019 | |
| Biotissue Holdings INC. | $19.68 | 2019 | |
| Aerie Pharmaceuticals, INC. | $16.93 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.20 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $13.96 | 2021 | |
| Eyepoint US, INC. | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ralstin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.